These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2790786)

  • 1. Epidermal growth factor receptor gene expression, protein kinase activity, and terminal differentiation of human malignant epidermal cells.
    King I; Sartorelli AC
    Cancer Res; 1989 Oct; 49(20):5677-81. PubMed ID: 2790786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The erbstatin analogue methyl 2,5-dihydroxycinnamate cross-links proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition.
    Stanwell C; Burke TR; Yuspa SH
    Cancer Res; 1995 Nov; 55(21):4950-6. PubMed ID: 7585535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
    Gulli LF; Palmer KC; Chen YQ; Reddy KB
    Cell Growth Differ; 1996 Feb; 7(2):173-8. PubMed ID: 8822200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431.
    Meuillet EJ; Kroes R; Yamamoto H; Warner TG; Ferrari J; Mania-Farnell B; George D; Rebbaa A; Moskal JR; Bremer EG
    Cancer Res; 1999 Jan; 59(1):234-40. PubMed ID: 9892212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epidermal growth factor-stimulated protein kinase in control of proliferation of A431 cells.
    Gill GN; Buss JE; Lazar CS; Lifshitz A; Cooper JA
    J Cell Biochem; 1982; 19(3):249-57. PubMed ID: 6296169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.
    Donato NJ; Yan DH; Hung MC; Rosenblum MG
    Cell Growth Differ; 1993 May; 4(5):411-9. PubMed ID: 8518234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors.
    Minke JM; Schuuring E; van den Berghe R; Stolwijk JA; Boonstra J; Cornelisse C; Hilkens J; Misdorp W
    Cancer Res; 1991 Aug; 51(15):4028-37. PubMed ID: 1649697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinoma.
    Nelson JM; Fry DW
    Exp Cell Res; 1997 Jun; 233(2):383-90. PubMed ID: 9194500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas.
    Petrides PE; Bock S; Bovens J; Hofmann R; Jakse G
    Cancer Res; 1990 Jul; 50(13):3934-9. PubMed ID: 2354442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the epidermal growth factor receptor by phosphorylation.
    Bertics PJ; Weber W; Cochet C; Gill GN
    J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the epidermal growth factor receptor gene expression in a morphological variant isolated from an epidermal growth factor receptor-deficient small cell lung carcinoma cell line.
    Gamou S; Shimosato Y; Shimizu N
    Cell Growth Differ; 1990 Aug; 1(8):351-9. PubMed ID: 1980602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells.
    Radinsky R; Risin S; Fan D; Dong Z; Bielenberg D; Bucana CD; Fidler IJ
    Clin Cancer Res; 1995 Jan; 1(1):19-31. PubMed ID: 9815883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck.
    Maxwell SA; Sacks PG; Gutterman JU; Gallick GE
    Cancer Res; 1989 Mar; 49(5):1130-7. PubMed ID: 2783883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells.
    Reiss M; Stash EB; Vellucci VF; Zhou ZL
    Cancer Res; 1991 Dec; 51(23 Pt 1):6254-62. PubMed ID: 1933886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
    Buss JE; Chouvet C; Gill GN
    J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cytokines on epidermal growth factor receptor expression by malignant trophoblast cells in vitro.
    Steller MA; Mok SC; Yeh J; Fulop V; Anderson DJ; Berkowitz RS
    J Reprod Med; 1994 Mar; 39(3):209-16. PubMed ID: 8035376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.